Stockreport

Takeda's HYQVIA Approved in Japan To Treat Immunodeficiency [Yahoo! Finance]

Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of)  (TAK) 
PDF Takeda Pharmaceutical Company Limited (NYSE: TAK ) announced on Friday that the Japanese Ministry of Health, Labour and Welfare has approved HYQVIA (Immune Globulin Inf [Read more]